Skip to main content
Article
A Phase II Trial of Radioimmunotherapy-Based Autologous Transplantation with I-131 Tositumomab, Cyclophosphamide and Etoposide in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Blood (2015)
  • Paul S Martin, Fred Hutchinson Cancer Research Center
  • Isaac C Jenkins, Fred Hutchinson Cancer Research Center
  • Theodore A Gooley, Fred Hutchinson Cancer Research Center
  • Damian J Green, Fred Hutchinson Cancer Research Center
  • John M Pagel, Fred Hutchinson Cancer Research Center
  • Sally J Lundberg, Fred Hutchinson Cancer Research Center
  • Lacey M Hedine, Fred Hutchinson Cancer Research Center
  • Joseph G Rajendran, University of Washington
  • Andrew T Shields, University of Washington
  • Darrell R Fisher, Pacific Northwest National Laboratory
  • David G Maloney, Fred Hutchinson Cancer Research Center
  • Frederick R Appelbaum, Fred Hutchinson Cancer Research Center
  • Ryan D Cassaday, University of Washington
  • Oliver W Press, Fred Hutchinson Cancer Research Center
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
Publication Date
December 3, 2015
Citation Information
Paul S Martin, Isaac C Jenkins, Theodore A Gooley, Damian J Green, et al.. "A Phase II Trial of Radioimmunotherapy-Based Autologous Transplantation with I-131 Tositumomab, Cyclophosphamide and Etoposide in Relapsed/Refractory Diffuse Large B-Cell Lymphoma" Blood Vol. 126 Iss. 23 (2015) p. 5502 - 5502
Available at: http://works.bepress.com/john-pagel/51/